(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -13.01%2.09B | 14.32%4.52B | 32.14%2.4B | 22.56%3.95B | 16.80%1.82B | 21.38%3.22B | 30.58%1.55B | -1.86%2.66B | -13.02%1.19B | 5.28%2.71B |
Operating income | -13.01%2.09B | 14.32%4.52B | 32.14%2.4B | 22.56%3.95B | 16.80%1.82B | 21.38%3.22B | 30.58%1.55B | -1.86%2.66B | -13.02%1.19B | 5.28%2.71B |
Cost of sales | 13.49%-514.51M | -10.88%-1.12B | -21.28%-594.72M | -24.48%-1.01B | -20.47%-490.38M | -21.77%-813.21M | -29.74%-407.07M | 7.81%-667.86M | 20.16%-313.75M | -4.36%-724.43M |
Operating expenses | 13.49%-514.51M | -10.88%-1.12B | -21.28%-594.72M | -24.48%-1.01B | -20.47%-490.38M | -21.77%-813.21M | -29.74%-407.07M | 7.81%-667.86M | 20.16%-313.75M | -4.36%-724.43M |
Gross profit | -12.85%1.57B | 15.51%3.39B | 36.17%1.8B | 21.90%2.94B | 15.50%1.32B | 21.25%2.41B | 30.88%1.15B | 0.32%1.99B | -10.14%876.37M | 5.62%1.98B |
Selling expenses | 20.27%-817.37M | -8.96%-1.98B | -24.29%-1.03B | -21.27%-1.82B | -17.45%-824.8M | -26.51%-1.5B | -24.99%-702.24M | -5.22%-1.19B | 1.30%-561.83M | -12.97%-1.13B |
Administrative expenses | -4.95%-145.21M | -16.69%-326.5M | -8.13%-138.37M | -9.06%-279.8M | -13.23%-127.97M | 6.15%-256.56M | 10.65%-113.01M | 0.84%-273.36M | 9.94%-126.49M | -7.57%-275.66M |
Research and development expenses | 7.16%-44.75M | 5.95%-110.46M | -68.11%-48.2M | -4.21%-117.45M | -14.57%-28.67M | -13.04%-112.71M | -24.03%-25.03M | 2.93%-99.71M | 55.97%-20.18M | 19.83%-102.72M |
Impairment and provision | 31.27%-4.29M | 38.38%-5.44M | -332.16%-6.24M | -25.74%-8.83M | -174.86%-1.44M | 97.03%-7.02M | 84.94%-525K | -429.75%-236.52M | ---3.49M | ---44.65M |
-Impairment of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -368.71%-168.73M | ---- | ---36M |
-Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4.07M | ---- | ---- |
-Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---56.79M | ---- | ---- |
-Other impairment is provision | 31.27%-4.29M | 38.38%-5.44M | -332.16%-6.24M | -25.74%-8.83M | -174.86%-1.44M | -1.53%-7.02M | 84.94%-525K | 20.03%-6.92M | ---3.49M | ---8.65M |
Special items of operating profit | 535.09%183.19M | 59.44%167.38M | 117.03%28.85M | 26.71%104.98M | -45.53%13.29M | -3.85%82.85M | -69.69%24.4M | -8.45%86.17M | -2.58%80.5M | 142.77%94.13M |
Operating profit | 20.97%743.76M | 38.96%1.14B | 73.09%614.85M | 32.62%818.56M | 7.44%355.23M | 121.25%617.22M | 35.01%330.63M | -46.96%278.97M | -19.02%244.89M | -1.33%525.96M |
Financing cost | -1,567.84%-2.85M | -334.44%-2.74M | 50.43%-171K | 49.76%-630K | 73.42%-345K | 92.45%-1.25M | 90.28%-1.3M | -524.53%-16.6M | -8,405.73%-13.35M | ---2.66M |
Special items of earning before tax | 114.05%121.17M | 6.47%105.51M | 0.15%56.61M | -4.84%99.1M | 10.64%56.53M | -21.50%104.14M | -27.30%51.09M | 11.04%132.66M | 47.30%70.28M | -12.19%119.47M |
Earning before tax | 28.42%862.08M | 35.25%1.24B | 63.17%671.29M | 27.35%917.03M | 8.15%411.41M | 82.29%720.1M | 26.05%380.42M | -38.54%395.02M | -13.76%301.81M | -3.94%642.77M |
Tax | -31.02%-235.6M | -39.38%-270.74M | -123.98%-179.82M | -18.86%-194.25M | -11.56%-80.29M | -63.44%-163.43M | -49.65%-71.97M | 28.38%-99.99M | 22.81%-48.09M | 14.48%-139.62M |
After-tax profit from continuing operations | 27.47%626.48M | 34.14%969.51M | 48.42%491.47M | 29.84%722.77M | 7.35%331.12M | 88.68%556.67M | 21.57%308.46M | -41.36%295.03M | -11.80%253.72M | -0.54%503.15M |
Earning after tax | 27.47%626.48M | 34.14%969.51M | 48.42%491.47M | 29.84%722.77M | 7.35%331.12M | 88.68%556.67M | 21.57%308.46M | -41.36%295.03M | -11.80%253.72M | -0.54%503.15M |
Profit attributable to shareholders | 27.47%626.48M | 34.14%969.51M | 48.42%491.47M | 29.84%722.77M | 7.35%331.12M | 88.68%556.67M | 21.57%308.46M | -41.36%295.03M | -11.80%253.72M | -0.54%503.15M |
Basic earnings per share | 27.69%0.83 | 33.33%1.28 | 47.73%0.65 | 29.73%0.96 | 7.32%0.44 | 89.74%0.74 | 24.24%0.41 | -39.06%0.39 | -8.33%0.33 | 3.23%0.64 |
Diluted earnings per share | 27.69%0.83 | 33.33%1.28 | 47.73%0.65 | 29.73%0.96 | 7.32%0.44 | 89.74%0.74 | 24.24%0.41 | -39.06%0.39 | -8.33%0.33 | 3.23%0.64 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data